Literature DB >> 6288755

Effect of sex steroids on beta-endorphin in hypophyseal portal blood.

S L Wardlaw, W B Wehrenberg, M Ferin, J L Antunes, A G Frantz.   

Abstract

Previous studies in female monkeys have shown that beta-endorphin (beta-EP) of hypothalamic origin is present in high concentrations in the hypophyseal portal blood and declines at the time of menses and after ovariectomy. In this study we have examined the effects of estradiol and progesterone replacement on portal blood beta-EP in ovariectomized monkeys. After acute iv administration of estradiol (2 micrograms), beta-EP did not rise from previously low levels (less than 133 pg/ml) over the ensuing 3 h. After chronic estradiol replacement for 3 weeks, portal beta-EP was detectable in 2 of 4 ovariectomized monkeys, with peak values of 341 and 733 pg/ml, respectively. When progesterone as well as estradiol were replaced chronically, high levels of beta-EP, [1610 +/- 192 (SE) pg/ml] were measured in all 13 portal blood samples collected from 4 ovariectomized monkeys. The majority of the beta-EP immunoactivity in these samples eluted from a Sephadex G-50 column in the same position as synthetic human beta-EP. Cation exchange chromatography showed that the majority of immunoactive beta-EP in portal plasma appeared to be nonacetylated beta-EP (1-31). We conclude that ovarian steroids are necessary for the release of hypothalamic beta-EP into portal blood and suggest that cyclic changes in sex steroids may affect anterior pituitary function in part via a mechanism involving hypothalamic beta-EP.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288755     DOI: 10.1210/jcem-55-5-877

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

Review 1.  Exercise and secondary amenorrhoea linked through endogenous opioids.

Authors:  M T Ruffin; R E Hunter; E A Arendt
Journal:  Sports Med       Date:  1990-08       Impact factor: 11.136

2.  Gonadal steroids do not affect basal growth hormone response to naloxone in humans.

Authors:  P Monteleone; M Maj; M Iovino; L Fiorenza; P M Fiumani; L Steardo
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 3.  The interaction between mediobasohypothalamic dopaminergic and endorphinergic neuronal systems as a key regulator of reproduction: an hypothesis.

Authors:  D D Rasmussen
Journal:  J Endocrinol Invest       Date:  1991-04       Impact factor: 4.256

4.  Evidence that the arcuate nucleus is an important site of progesterone negative feedback in the ewe.

Authors:  Robert L Goodman; Ida Holaskova; Casey C Nestor; John M Connors; Heather J Billings; Miro Valent; Michael N Lehman; Stanley M Hileman
Journal:  Endocrinology       Date:  2011-06-21       Impact factor: 4.736

5.  The hypothalamic-pituitary-luteal axis in women: effects of long-term orally active opioid antagonist (naltrexone) administration.

Authors:  A M Fulghesu; A Lanzone; R Apa; M Guido; M Ciampelli; F Cucinelli; A Caruso; S Mancuso
Journal:  J Endocrinol Invest       Date:  1997 Jul-Aug       Impact factor: 4.256

6.  The effects of prolonged opioidergic blockade on LH pulsatile secretion during the menstrual cycle.

Authors:  W G Rossmanith; U Wirth; K Sterzik; S S Yen
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

7.  Progesterone increased β-endorphin innervation of the locus coeruleus, but ovarian steroids had no effect on noradrenergic neurodegeneration.

Authors:  Fernanda B Lima; Cristiane M Leite; Cynthia L Bethea; Janete A Anselmo-Franci
Journal:  Brain Res       Date:  2017-03-08       Impact factor: 3.252

Review 8.  Physical exercise and menstrual cycle alterations. What are the mechanisms?

Authors:  H A Keizer; A D Rogol
Journal:  Sports Med       Date:  1990-10       Impact factor: 11.136

9.  Effects of estradiol on cerebrospinal fluid levels of agouti-related protein in ovariectomized rhesus monkeys.

Authors:  Ennian Xiao; Andrea J Kim; Roxanne Dutia; Irene Conwell; Michel Ferin; Sharon L Wardlaw
Journal:  Endocrinology       Date:  2010-01-07       Impact factor: 4.736

Review 10.  New concepts in the regulation of hypothalamic gonadotropin releasing hormone (GnRH) secretion.

Authors:  D D Rasmussen
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.